《大行報告》瑞銀下調港交所(00388.HK)目標價至475元 評級「買入」
瑞銀發表報告指,港交所(00388.HK)第二季至今的成交額和新股上市數目均低於預期,將其2022至2024年稅後淨利潤預測下調8%-11%,將目標價從520元下調至475元,評級「買入」,因為其將每日平均成交額下調11%-12%,預計2022-2024年日均成交額將介乎1,350億元至1,860億元。
瑞銀對港交所在市場擴張、速度加速和收入多元化方面的長期前景保持積極看法,雖然針對倫敦金屬交易所暫停鎳交易的訴訟暗示一些風險,但短期內不太可能看到裁決,認為投資者將關注基本面驅動因素和下半年複蘇進度。
瑞銀指,自投資者的反饋以及恆生科技指數近期的強勢表明,港交所可能會受益於市場情緒的改善,催化劑包括內地企業在美國上市預託證券回歸、MSCI A股期貨市場份額增加、IPO活動再度活躍以及本港拆息上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.